Humasis Co. Ltd. (KOSDAQ:205470)
South Korea · Delayed Price · Currency is KRW 1,393.00
+6.00 (0.43%)
Sep 18, 2025, 3:30 PM KST
Humasis Market Cap
Humasis has a market cap or net worth of 156.94 billion as of September 18, 2025. Its market cap has decreased by -42.45% in one year.
Market Cap
156.94B
Enterprise Value
12.32B
Revenue
37.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,393.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 156.94B, an increase of 1,358.15%. That is a compound annual growth rate of 39.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 157.62B | -14.91% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | 324.84B | 729.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.59T |
| Celltrion | 37.45T |
| ALTEOGEN | 26.27T |
| Yuhan | 8,902.50B |
| SK Biopharmaceuticals | 8,669.28B |
| Peptron | 6,977.56B |
| PharmaResearch | 6,503.92B |
| ABL Bio | 5,686.72B |